Subscribe to NRx Newsletter

Investor FAQ

What are NRx Pharmaceuticals, Inc.'s stock and warrant symbols?

Our stock is traded on the Nasdaq under the symbol NRXP.
Our public warrants are traded on the Nasdaq under the symbol NRXPW.

When was NRx Pharmaceuticals, Inc. incorporated?

The Company was incorporated on September 18, 2017, as Big Rock Partners Acquisition Corp. (“BRPA”) and became a public company on November 17, 2017. Upon the reverse merger of a wholly owned subsidiary of BRPA and NeuroRx, Inc., BRPA changed its name to NRx Pharmaceuticals, Inc. The Company’s subsidiary, NeuroRx Inc., was incorporated on May 20, 2015.

Where is NRx Pharmaceuticals, Inc. located?

The Company’s registered address is 1201 Orange Street, Suite 600, Wilmington Delaware 19801 and its mailing address is 1201 N. Market Street, Suite 111, Wilmington, DE 19801.

When is NRx Pharmaceuticals, Inc.'s fiscal year end?

December 31st

When is your annual shareholder’s meeting?

We expect to hold the annual shareholder’s meeting in May or June of 2023.

What is your market size?

There are approximately 7 million adults with bipolar disorder and 680,000 suffer from either acute or sub-acute suicidal ideation. Someone in the U.S. attempts suicide every 27 seconds. Currently, there are no FDA approved medicines today focused on treatment of people with bipolar depression and acute or sub-acute suicidality.

Who is NRx Pharmaceuticals, Inc.'s transfer agent?

Continental Stock Transfer & Trust Company

Who is NRx Pharmaceuticals, Inc.'s independent auditor?

1 John F Kennedy Pkwy
Short Hills, NJ 07078

Who is NRx Pharmaceuticals, Inc.'s outside legal counsel?

Douglas Boggs
500 8th St., N.W.
Washington, DC 20004

Corporate Presentation

Click here to view our corporate presentation or on the image below

Bottom Global Links (above footer)